William J Gradishar

William J Gradishar

UNVERIFIED PROFILE

Are you William J Gradishar?   Register this Author

Register author
William J Gradishar

William J Gradishar

Publications by authors named "William J Gradishar"

Are you William J Gradishar?   Register this Author

100Publications

2679Reads

13Profile Views

Current state of clinical trials in breast cancer brain metastases.

Neurooncol Pract 2019 Sep 11;6(5):392-401. Epub 2019 Feb 11.

Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nop/npz003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753353PMC
September 2019

Relationship of pathological features and a 21 gene expression assay in younger versus older women with node-negative endocrine receptor-positive breast cancer.

Breast Cancer Res Treat 2019 Jul 11;176(1):95-100. Epub 2019 Apr 11.

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 201 N. Broadway, Rm 10262, Baltimore, MD, 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-018-05088-6DOI Listing
July 2019

A novel small-molecule antagonizes PRMT5-mediated KLF4 methylation for targeted therapy.

EBioMedicine 2019 Jun 14;44:98-111. Epub 2019 May 14.

Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, United States; Department of Pharmacology, Northwestern University Feinberg School of Medicine, United States; Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, United States. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S23523964193031
Publisher Site
http://dx.doi.org/10.1016/j.ebiom.2019.05.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6604046PMC
June 2019

NCCN Guidelines Updates: Breast Cancer.

J Natl Compr Canc Netw 2019 May;17(5.5):552-555

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2019.5006DOI Listing
May 2019

Adjuvant Anthracyclines in Breast Cancer: What Is Their Role?

Oncologist 2018 10 17;23(10):1153-1161. Epub 2018 Aug 17.

Lynn Sage Breast Cancer Program, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2017-0672DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6263120PMC
October 2018

Phase I study of alpelisib (BYL-719) and trastuzumab emtansine (T-DM1) in HER2-positive metastatic breast cancer (MBC) after trastuzumab and taxane therapy.

Breast Cancer Res Treat 2018 Sep 30;171(2):371-381. Epub 2018 May 30.

Lynn Sage Breast Cancer Program, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, 676 N St. Clair St. Suite 850, Chicago, IL, 60611, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-018-4792-0
Publisher Site
http://dx.doi.org/10.1007/s10549-018-4792-0DOI Listing
September 2018

From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor Sequencing.

Value Health 2018 09 3;21(9):1062-1068. Epub 2018 Aug 3.

Department of Clinical Pharmacy, UCSF Center for Translational and Policy Research on Personalized Medicine (TRANSPERS), University of California San Francisco, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10983015183226
Publisher Site
http://dx.doi.org/10.1016/j.jval.2018.06.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374027PMC
September 2018

Advances in Endocrine Therapy for Postmenopausal Metastatic Breast Cancer.

Cancer Treat Res 2018;173:141-154

Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-319-70197-4_9DOI Listing
June 2018

Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review.

Breast Cancer Res Treat 2018 Jun 7;169(3):397-406. Epub 2018 Feb 7.

Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-018-4697-yDOI Listing
June 2018

NCCN Guidelines Updates: Breast Cancer.

J Natl Compr Canc Netw 2018 05;16(5S):605-610

Presented by Sharon H. Giordano, MD, MPH, The University of Texas MD Anderson Cancer Center, Houston, Texas; Anthony D. Elias, MD, University of Colorado Cancer Center, Aurora, Colorado; and William J. Gradishar, MD, Feinberg School of Medicine at Northwestern University, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://www.jnccn.org/lookup/doi/10.6004/jnccn.2018.0043
Publisher Site
http://dx.doi.org/10.6004/jnccn.2018.0043DOI Listing
May 2018

Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer: ALTERNATIVE.

J Clin Oncol 2018 03 15;36(8):741-748. Epub 2017 Dec 15.

Stephen R.D. Johnston, The Royal Marsden NHS Foundation Trust, London; Lisa S. Williams, Novartis Pharmaceuticals UK Limited, Frimley, United Kingdom; Roberto Hegg, Centro de Referência da Saúde da Mulher; Sergio D. Simon, Hospital Israelita Albert Einstein, São Paulo, Brazil; Seock-Ah Im, Seoul National University College of Medicine, Seoul; In Hae Park, National Cancer Center, Gyeonggi-do, Korea; Olga Burdaeva, Regional Oncology Dispensary, Arkhangelsk; Sergei Tjulandin, N.N. Blokhin Russian Cancer Research Center, Moscow, Russia; Galina Kurteva, University Cancer Center Hospital, Sofia, Bulgaria; Michael F. Press, University of Southern California, Los Angeles, CA; Hiroji Iwata, Aichi Cancer Center Hospital, Aichi, Japan; Sarah Kenny, Severine Sarp, and Miguel A. Izquierdo, Novartis Pharma AG, Basel, Switzerland; and William J. Gradishar, Northwestern University, Chicago, IL.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.74.7824
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.74.7824DOI Listing
March 2018

Do Genomic Assays Provide the Necessary Confidence to De-escalate Adjuvant Therapy?

J Clin Oncol 2018 03 26;36(8):725-727. Epub 2018 Jan 26.

Ricardo L.B. Costa, H. Lee Moffitt Cancer Center, Tampa, FL; and William J. Gradishar, Northwestern University, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.9802DOI Listing
March 2018

Cell-Free DNA and Circulating Tumor Cells: Comprehensive Liquid Biopsy Analysis in Advanced Breast Cancer.

Clin Cancer Res 2018 02 27;24(3):560-568. Epub 2017 Nov 27.

Department of Medicine-Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-2092DOI Listing
February 2018

Long-term outcomes in cancer patients who did or did not pursue fertility preservation.

Fertil Steril 2018 02 17;109(2):349-355. Epub 2018 Jan 17.

Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.fertnstert.2017.10.029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815903PMC
February 2018

Differences Are Important: Breast Cancer Therapy in Different Ethnic Groups.

J Glob Oncol 2017 Aug 11;3(4):281-284. Epub 2017 Apr 11.

Feinberg School of Medicine and Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JGO.2017.009936DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5560466PMC
August 2017

Breast Cancer Outcomes After Diagnosis of Hormone-positive Breast Cancer and Subsequent Pregnancy in the Tamoxifen Era.

Clin Breast Cancer 2017 07 9;17(4):e185-e189. Epub 2017 Jan 9.

Northwestern University Feinberg School of Medicine, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2016.12.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482759PMC
July 2017

Endocrine Therapy in the Current Management of Postmenopausal Estrogen Receptor-Positive Metastatic Breast Cancer.

Oncologist 2017 05 17;22(5):507-517. Epub 2017 Mar 17.

Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2015-0464DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423509PMC
May 2017

Triple-Negative Breast Cancer: Current Practice and Future Directions.

J Oncol Pract 2017 05;13(5):301-303

Feinberg School of Medicine and Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2017.023333DOI Listing
May 2017

New Approaches to Endocrine Therapy for Breast Cancer.

J Natl Compr Canc Netw 2017 05;15(5S):679-681

Presented by William J. Gradishar, MD, Maggie Daley Center for Women's Cancer Care, Breast Medical Oncology, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2017.0071DOI Listing
May 2017

Developmental therapeutics for inflammatory breast cancer: Biology and translational directions.

Oncotarget 2017 Feb;8(7):12417-12432

Developmental Therapeutics Program, Division of Hematology/Oncology, Feinberg School of Medicine, Chicago, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.13778DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355355PMC
February 2017

Targeting Epidermal Growth Factor Receptor in triple negative breast cancer: New discoveries and practical insights for drug development.

Cancer Treat Rev 2017 Feb 5;53:111-119. Epub 2017 Jan 5.

Developmental Therapeutics Program, Division of Hematology/Oncology, Feinberg School of Medicine, Chicago, USA; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2016.12.010DOI Listing
February 2017

Issues in Breast Cancer Survivorship: Optimal Care, Bone Health, and Lifestyle Modifications.

Am Soc Clin Oncol Educ Book 2016 ;35:e22-9

From the UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; Massachusetts General Hospital Cancer Center, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_159203DOI Listing
January 2017

Care for a Patient With Cancer As a Project: Management of Complex Task Interdependence in Cancer Care Delivery.

J Oncol Pract 2016 11 31;12(11):1101-1113. Epub 2016 Oct 31.

Center for Business Models in Healthcare; Northwestern University, Chicago, IL; University of Michigan Health System; University of Michigan Medical School, Ann Arbor, MI; ECOG/ACRIN Cancer Research Group, Philadelphia, PA; National Breast Cancer Coalition, Washington, DC; Genentech, South San Francisco, CA; Albert Einstein Cancer Center; Albert Einstein College of Medicine, Bronx; The Leukemia & Lymphoma Society, Rye Brook, NY; Brown University School of Public Health, Providence, RI; Wake Forest University School of Medicine; and Comprehensive Cancer Center of Wake Forest University, Winston-Salem, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2016.013573DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455414PMC
November 2016

Treatment challenges for community oncologists treating postmenopausal women with endocrine-resistant, hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer.

Cancer Manag Res 2016 11;8:85-94. Epub 2016 Jul 11.

Division of Hematology/Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/CMAR.S98249DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946864PMC
July 2016

Breast cancer and immunology: biomarker and therapeutic developments.

Expert Rev Anticancer Ther 2015 10;15(10):1215-22. Epub 2015 Sep 10.

c 3 Northwestern University Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Department of Medicine, Division of Oncology, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.2015.1086270DOI Listing
May 2016

NCCN Guidelines Insights Breast Cancer, Version 1.2016.

J Natl Compr Canc Netw 2015 Dec;13(12):1475-85

From Robert H. Lurie Comprehensive Cancer Center of Northwestern University; University of Washington/Seattle Cancer Care Alliance; UCSF Helen Diller Family Comprehensive Cancer Center; UC San Diego Moores Cancer Center; Dana-Farber/Brigham and Women's Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; University of Colorado Cancer Center; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; University of Alabama at Birmingham Comprehensive Cancer Center; The University of Texas MD Anderson Cancer Center; Mayo Clinic Cancer Center; Fox Chase Cancer Center; Memorial Sloan Kettering Cancer Center; Massachusetts General Hospital Cancer Center; Duke Cancer Institute; Vanderbilt-Ingram Cancer Center; Yale Cancer Center/Smilow Cancer Hospital; University of Michigan Comprehensive Cancer Center; Fred & Pamela Buffett Cancer Center; Roswell Park Cancer Institute; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Research Advocacy Network; Moffitt Cancer Center; City of Hope Comprehensive Cancer Center; Stanford Cancer Institute; Huntsman Cancer Institute at the University of Utah; and National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2015.0176DOI Listing
December 2015

Changing Treatment Paradigms in Metastatic Breast Cancer: Lessons Learned.

JAMA Oncol 2015 Jul;1(4):528-34; quiz 549

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.1198DOI Listing
July 2015

Optimizing Treatment of HER2-Positive Breast Cancer.

J Natl Compr Canc Netw 2015 May;13(5 Suppl):649-51

Presented by William J. Gradishar, MD, Betsy Bramsen Professor of Breast Oncology, Director of the Maggie Daley Center for Women's Cancer Care at Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2015.0193DOI Listing
May 2015

Refining Treatment Decisions in Older Patients With Breast Cancer.

JAMA Oncol 2015 May;1(2):166-7

Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.32DOI Listing
May 2015

No pain, no gain: a fallacy so far.

J Clin Oncol 2015 Jan 15;33(3):235-7. Epub 2014 Dec 15.

Northwestern University, Chicago, IL

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.59.0919DOI Listing
January 2015

Yttrium-90 radioembolization stops progression of targeted breast cancer liver metastases after failed chemotherapy.

J Vasc Interv Radiol 2014 Oct 22;25(10):1523-32, 1532.e1-2. Epub 2014 Aug 22.

Department of Radiology and Section of Interventional Radiology, Northwestern University Feinberg School of Medicine, Chicago. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jvir.2014.07.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720166PMC
October 2014

Biomarker testing for breast, lung, and gastroesophageal cancers at NCI designated cancer centers.

J Natl Cancer Inst 2014 Oct 12;106(10). Epub 2014 Sep 12.

Northwestern University Feinberg School of Medicine, Chicago, IL (JCS, JRT, CBW, KPS, AWR, JDP, ABB, WJG); Center for Business Models in Healthcare, Chicago, IL (JRT, CBW); UCSF Center for Translational and Policy Research on Personalized Medicine, Department of Clinical Pharmacy, University of California, San Francisco, CA (JRT); Department of Pathology, Dartmouth Hitchcock Medical Center and the Audrey and Theodor Geisel School of Medicine, Dartmouth College, Lebanon, NH (GJT); Mayo Clinic Cancer Center, Mayo Clinic, Jacksonville, FL (EAP).* Current affiliation: Spectrum Health Medical Group, Grand Rapids, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju256DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4176043PMC
October 2014

Evidence-driven, patient-specific approaches for optimizing survival prolongation in breast cancer.

Clin Adv Hematol Oncol 2014 Aug;12(8 Suppl 15):3-21; quiz 22

Feinberg School of Medicine at Northwestern University, Chicago, Illinois.

View Article

Download full-text PDF

Source
August 2014

The application of Oncotype DX in early-stage lymph-node-positive disease.

Curr Oncol Rep 2014 ;16(1):360

Division of Hematology/Oncology, Department of Medicine and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, 676 N. St Clair, Suite 850, Chicago, IL, 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-013-0360-2DOI Listing
June 2014

Treatment of metastatic breast cancer.

J Natl Compr Canc Netw 2014 May;12(5 Suppl):759-61

Presented by William J. Gradishar, MD, Betsy Bramsen Professor of Breast Oncology, Division of Hematology and Medical Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2014.0184DOI Listing
May 2014

Satisfaction with work-life balance and the career and retirement plans of US oncologists.

J Clin Oncol 2014 Apr 10;32(11):1127-35. Epub 2014 Mar 10.

Tait D. Shanafelt, Daniel Satele, and Jeff Sloan, Mayo Clinic, Rochester, MN; Marilyn Raymond, William Benton Clark, and Amy E. Hanley, American Society of Clinical Oncology, Alexandria, VA; Michael Kosty, Scripps Clinic, La Jolla; Helen Chew, University of California at Davis, Davis, CA; Leora Horn, Vanderbilt University Medical Center, Nashville, TN; John Pippen, Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX; Quyen Chu, Louisiana State University Health Sciences Center, Shreveport, LA; and William J. Gradishar, Northwestern University, Evanston, IL.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2013.53.4560
Publisher Site
http://dx.doi.org/10.1200/JCO.2013.53.4560DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876331PMC
April 2014

Burnout and career satisfaction among US oncologists.

J Clin Oncol 2014 Mar 27;32(7):678-86. Epub 2014 Jan 27.

Tait D. Shanafelt, Daniel Satele, Jeff Sloan, Mayo Clinic, Rochester, MN; William J. Gradishar, Northwestern University, Evanston, IL; Michael Kosty, Scripps Clinic, La Jolla; Helen Chew, University of California Davis, Davis, CA; Leora Horn, Vanderbilt University Medical Center, Nashville, TN; Ben Clark, Amy E. Hanley, Marilyn Raymond, American Society of Clinical Oncology, Alexandria, VA; Quyen Chu, Louisiana State University Health Sciences Center, Shreveport, LA; and John Pippen, Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.51.8480DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3927737PMC
March 2014

Quality of life in patients with metastatic breast cancer.

Clin Adv Hematol Oncol 2014 Feb;12 Suppl 4(2):3-4

Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL.

View Article

Download full-text PDF

Source
February 2014

Individualizing treatment to optimize survival outcomes in breast cancer.

Clin Adv Hematol Oncol 2013 Aug;11 Suppl 10(8):3-21

The West Clinic Memphis, TN.

View Article

Download full-text PDF

Source
August 2013

Nab-paclitaxel for first-line treatment of patients with metastatic breast cancer and poor prognostic factors: a retrospective analysis.

Breast Cancer Res Treat 2013 Apr 6;138(3):829-37. Epub 2013 Apr 6.

Baylor Sammons Cancer Center, Texas Oncology and The US Oncology Network, 3410 Worth Street, Ste 400, Dallas, TX 75246, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-013-2447-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3631516PMC
April 2013

Author's reply to Lamy.

J Natl Cancer Inst 2013 Jan;105(2):149-50

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djs493DOI Listing
January 2013

The role of targeted therapy and biomarkers in breast cancer treatment.

Clin Exp Metastasis 2012 Oct 13;29(7):807-19. Epub 2012 Jun 13.

University of Arizona Cancer Center, 1515N. Campbell Avenue, Tucson, AZ 85724, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10585-012-9496-yDOI Listing
October 2012

Sorafenib in locally advanced or metastatic breast cancer.

Expert Opin Investig Drugs 2012 Aug 23;21(8):1177-91. Epub 2012 May 23.

Maggie Daley Center for Women's Cancer Care, Northwestern University Feinberg School of Medicine, Northwestern Memorial Hospital, Robert H. Lurie Comprehensive Cancer Center, 676 N St Clair St, Suite 850, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543784.2012.689824DOI Listing
August 2012

Barriers to the use of personalized medicine in breast cancer.

J Oncol Pract 2012 Jul 22;8(4):e24-31. Epub 2012 May 22.

Center for Business Models in Healthcare, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2011.000448DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3396824PMC
July 2012

Diagnostic and treatment considerations when newly diagnosed breast cancer coincides with pregnancy: a case report and review of literature.

J Natl Compr Canc Netw 2012 Feb;10(2):145-8

Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2012.0017DOI Listing
February 2012

HER2 therapy--an abundance of riches.

N Engl J Med 2012 Jan 7;366(2):176-8. Epub 2011 Dec 7.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMe1113641DOI Listing
January 2012

The place for eribulin in the treatment of metastatic breast cancer.

Curr Oncol Rep 2011 Feb;13(1):11-6

Maggie Daley Center for Women's Cancer Care, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-010-0145-9DOI Listing
February 2011

Adjuvant endocrine therapy for early breast cancer: the story so far.

Cancer Invest 2010 May;28(4):433-42

Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/07357901003631098DOI Listing
May 2010

A phase II trial of trastuzumab plus weekly ixabepilone and carboplatin in patients with HER2-positive metastatic breast cancer: an Eastern Cooperative Oncology Group Trial.

Breast Cancer Res Treat 2010 Feb;119(3):663-71

Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, 1155 Pressler Street,Unit 1354, P.O. Box 301438, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-009-0658-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3133687PMC
February 2010

Significantly longer progression-free survival with nab-paclitaxel compared with docetaxel as first-line therapy for metastatic breast cancer.

J Clin Oncol 2009 Aug 26;27(22):3611-9. Epub 2009 May 26.

Northwestern University, Breast Oncology, Division of Hematology/Oncology, Department of Medicine, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.18.5397DOI Listing
August 2009

Clinical roundtable monograph: a multidisciplinary approach to the use of oncotype DX in clinical practice.

Clin Adv Hematol Oncol 2009 Apr;7(4):1-7

Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, Evanston, IL, USA.

View Article

Download full-text PDF

Source
April 2009

alphaB-crystallin is a novel predictor of resistance to neoadjuvant chemotherapy in breast cancer.

Breast Cancer Res Treat 2008 Oct 30;111(3):411-7. Epub 2007 Oct 30.

Department of Surgery, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-007-9796-0DOI Listing
October 2008

Case records of the Massachusetts General Hospital. Case 30-2008. A 47-year-old woman with a mass in the breast and a solitary lesion in the spine.

N Engl J Med 2008 Sep;359(13):1382-91

Department of Medicine, Northwestern University, and the Feinberg School of Medicine, Chicago, USA.

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMcpc0805308
Publisher Site
http://dx.doi.org/10.1056/NEJMcpc0805308DOI Listing
September 2008

A phase II study of single agent bortezomib in patients with metastatic breast cancer: a single institution experience.

Cancer Invest 2007 Dec 18;25(8):733-7. Epub 2007 Oct 18.

Department of Medicine, Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, and the Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/07357900701506573DOI Listing
December 2007

Counterpoint: the argument for combination chemotherapy in the treatment of metastatic breast cancer.

J Natl Compr Canc Netw 2007 Sep;5(8):673-5

Northwestern University, Feinberg School of Medicine, Chicago, Illinois 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2007.0069DOI Listing
September 2007

Albumin-bound paclitaxel: a next-generation taxane.

Expert Opin Pharmacother 2006 Jun;7(8):1041-53

Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.7.8.1041DOI Listing
June 2006

Selective estrogen receptor modulators and prevention of invasive breast cancer.

JAMA 2006 Jun 5;295(23):2784-6. Epub 2006 Jun 5.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.295.23.jed60037DOI Listing
June 2006